NEWS2020-11-25T12:15:08+00:00

PD-MitoQUANT researchers take part in Parkinson’s UK online conference

The theme of the 2-day 2020 Parkinson's-UK conference was "Accelerating research and improving care." Keynote lectures were delivered live from around the world. Several researchers from PD-MitoQUANT partner organisations were involved. At the September 24th and 25th meeting, research was presented by Prof Donato Di Monte of the German Center for Neurodegenerative Diseases (DZNE), and from the RCSI (Royal College of Surgeons Ireland) Dr Niamh Connolly.  University College London (UCL)'s Dr Sonia Gandhi and Prof David Dexter from Parkinson’s UK  both chaired a range of sessions, including one focusing on mechanisms of neurodegeneration and another introducing new and emerging drug therapies emerging therapeutic strategies. Prof DiMonte's talk, "Modelling alpha-synuclein pathology in vivo" was delivered on the second day. A research study by Sandeep Chenna, Alvin Joselin, David Park, Jochen H. M. Prehn, and Niamh M. C. Connolly  was presented as a poster entitled: "Systems modelling of mitochondrial bioenergetics enables [...]

October 6th, 2020|

Dr Shruti Desai, Radboud University Nijmegen Medical Center features in latest Neuronet campaign

Dr Shruti Desai is a postdoctoral researcher and Cellular Bioenergetics group member at Radboud University Nijmegen Medical Center within the Radboud Center for Mitochondrial Medicine (RCMM). Here, she works alongside mitochondrial experts on clinical care, diagnostics and fundamental research to conduct morphofunctional in vitro studies in living and fixed cells using super-resolution analysis of mitochondria. On September 24, 2020, Shruti responded to questions about her work for the Neuronet project (https://www.imi-neuronet.org/) as part of their series of interviews where they shine a spotlight on early-career investigators. Read the entire interview here.  

September 28th, 2020|

Neuronet launches campaign: “The value of public-private collaboration & findings highlights”

The Neuronet project (https://www.imi-neuronet.org/) is currently comprised of 18 IMI projects, including PD-MitoQUANT. Today, September 11, 2020, they have launched a new platform to boost collaboration across research projects focusing on neurodegenerative diseases. Neuronet’s communication team and our community of communication representatives from the Innovative Medicines Initiative projects on neurodegeneration are pleased to celebrate the great people behind the projects through an annual Neuronet campaign on social media. A profile of Dr Orla Watters, a member of the PD-MitoQUANT research team at the RCSI (Royal College of Surgeons Ireland) will feature early in the campaign. Later, it featured Dr Shruti Desai of Radboud University Nijmegen Medical Center and Dana Bar-On at Teva Pharmaceutical Industries. Neuronet initiated the new campaign to highlight the value of public-private collaboration and to capitalise on the increased public attention on neurodegenerative diseases during World Alzheimer’s Month. The social media campaign will conclude on October 20th, in time [...]

September 11th, 2020|

Check out our latest newsletter!

In the latest version of our newsletter, we hear from Richard Campbell about his experience as a person with Parkinson's joining our research meeting and interview two members of the research team. You can download the full newsletter here!

August 6th, 2020|

PD-MitoQUANT features in the current SYNAPSE eNewsletter

SYNAPSE is the Parkinson's UK quarterly newsletter for researchers. Typically, it publishes useful information about research funding, as well as events, news and opportunities in the world of research. The latest issue includes a small feature about the role of volunteers within the PD-MitoQUANT project and links to our March interview with Paula Scurfield. Read the story and the entire issue here. You can subscribe to SYNAPSE, the eNewsletter for the Parkinson's research community here.

August 4th, 2020|
Go to Top